Research Highlights

Back to News Archive
 
Vitamin D levels not linked to asthma or dermatitis
Vitamin D supplementation is unlikely to reduce the risk of asthma in children or adults, atopic dermatitis, or allergies according to a new study published in PLOS Medicine by Brent Richards, Associate Professor at McGill University and senior investigator at the Lady Davis Institute at the Jewish General Hospital in Montreal, Canada, and colleagues.

Some previous epidemiological studies have suggested that low vitamin D levels are associated with increased rates of asthma, atopic dermatitis—an itchy inflammation of the skin—and elevated levels of IgE, an immune molecule linked to atopic disease (allergies). In the new work, researchers looked at genetic and health data on more than 100,000 individuals from previous large studies to determine whether genetic alterations that are associated with vitamin D levels predispose people to asthma, dermatitis, or high IgE levels.

“Our findings suggest that previous associations between low vitamin D and atopic disease could be due to spurious associations with other factors,” said Dr. Despoina Manousaki the lead author and PhD student at the Lady Davis Institute. “Efforts to increase vitamin D levels will probably not result in decreased risk of adult and pediatric asthma, atopic dermatitis, or elevated IgE levels.”

There was no statistically significant difference between rates of asthma (including childhood-onset asthma), atopic dermatitis, or IgE levels in people with and without any of the four genetic changes associated with lower levels of 25-hydroxyvitamin D. However, the results do not exclude an association between the outcomes and levels of 1,25-dihydroxyvitamin D, the active form of the vitamin, and more work will be needed to determine if the results hold true in non-European populations and in people with vitamin D deficiency.

These findings do contrast a recent study from the same group which used similar methods to provide evidence supporting a causal role for vitamin D in the risk of multiple sclerosis, a common neurological disorder. “Our previous findings suggest that low vitamin D levels increase risk for some inflammatory diseases like multiple sclerosis, but these effects do not translate to other inflammatory diseases like asthma and atopic dermatitis”, said Dr. Richards. This suggests that people at risk for multiple sclerosis should ensure that they have adequate vitamin D levels, but that efforts to increase vitamin D levels would not be expected to protect against asthma.

For further information or to arrange interviews with Dr. Richards, contact:

Tod Hoffman
Research Communications Officer
Lady Davis Institute at the Jewish General Hospital
Office: 514-340-8222, ext. 28661
thoffman@jgh.mcgill.ca

Support research at the Lady Davis Institute - Jewish General Hospital